PowerPoint Presentation

International business analysis on Beximco Pharmaceuticals

name

Ehsan Karim

Kasmin Younus

MD. Nawaz Sharif Tanvir

Mumtahena Khorshed

Faria Ejaj

Abhishek Nandi

Ayesha Iqbal Pinky

Palida Afrin

id

101 0347 030

112 0049 030

111 0411 030

111 1034 030

111 0559 530

111 0923 030

111 0365 030

111 0549 030

Company overview

Beximco Pharmaceuticals is one of the largest exporters of medicines in Bangladesh, winning National Export (Gold) Trophy for a record three times

BPL mainly use the low cost strategy for international business, their focus on cost leadership with broader target as a competitive scope

Hong Kong (Export), Russia (Export), Singapore (Strategic Alliance), Pakistan (WHS), Myanmar (Export), Afghanistan & Soloman Island (WHS), Kenya (WHS), South Africa & Netherlands (Contract) etc.

322 products registered in Asia, 91 in Africa, five in Central and Latin America, and 22 in Middle East

Country 1: Singapore

HDI Index: 0.901 => Ranking 9th (2014)

Future growth of Singapore will be even higher with current business-location growth strategy while meeting the expectations of an affluent and rapidly ageing society

knowledge-based economy (KBE) and targeting for new niches

Currently facing ageing demographics, economic restructuring and a current economic slowdown and it is certainly a paternalistic one

free-enterprise economy with average tariff rate of 0 percent, and there are few non-tariff barriers

global standardization strategy => pressure for cost reduction is quiet high & pressure for qualities and measurement standards for drug supplies

Country 2: Hong Kong

BPL started its first exports of API to Hong Kong in 1992

HDI Index: 0.892 => Ranking 15th (2014)

Future growth is stable but rapid economic growth by expanding domestic demand with social development strategy by upgrading social services

knowledge-based economy (KBE) and being collectivist by a number of studies

Hong Kong has been ranked as the world's freest economy for the past 18 years

economic, social and political development, the Hong Kong government is expected to become more interventionist

free-enterprise economy with 0 percent average tariff rate and few barriers to foreign investment and no restrictions on foreign banks

global standardization strategy => pressure for cost reduction is quiet high & pressure for qualities and measurement standards for drug supplies

Country 3: Myanmar

HDI Index: 0.524 => Ranking 150th (2014)

With underdeveloped institutional capabilities, poor revenue performance has led to persistent fiscal deficits, which have been financed by the central bank

Myanmar has transitioned from a direct military dictatorship to a formally democratic system and has embarked on a period of rapid economic reform

Political economy of Myanmars dual transition from state socialism to capitalism and from dictatorship to democracy

Government has promised to pursue a course of political and economic liberalization, corruption remains pervasive

Myanmars average tariff rate is 3.2 percent; Numerous non-tariff barriers further impede trade where state-owned banks dominate the underdeveloped financial sector

New foreign investment law and international strategy where pressure for cost is low with less responsiveness to local pressures